Proactiveinvestors recommends

Additional Information

Market:	ASX
Sector:	General Mining
EPIC:	YTC
Latest Price:	0.43 (-1.15% )
52-week High:	0.79
52-week Low:	0.39
Market Cap:	106.95M

1 year chart

1 day chart

YTC Resources Full YTC Resources profile here

YTC Resources (ASX: YTC) is focussed on the development and exploration of the high grade Hera-Nymagee Project in the Cobar district of NSW.

The company has completed the Definitive Feasibility Study (DFS) on the Hera gold and base metal deposit as Stage 1 of the development of the Hera-Nymagee Project. Stage 2 of the Feasibility study will look at the integration of the larger Nymagee copper deposit, located 4.5km to the north of Hera.

YTC Resources returns more high grade intercepts at Hera Gold project

Wednesday, March 10, 2010

YTC Resources (ASX: YTC) has followed up past strong drill results with further high grade results from drilling as part of the Definitive Feasibility Study into mining the 100% owned Hera Gold Project.

New high-grade gold, lead-zinc intersections have substantially extended the Hera Deposit along an open northerly plunge. Best results included:

- 6.8m @ 15.42g/t Au, 2.86% Pb, 2.6% Zn from 475.5m; 3m @ 15.52g/t Au, 33g/t Ag, 0.4% Cu, 4.5% Pb, 3.5% Zn from 489m and 10.2m @ 3.23g/t Au, 16g/t Ag, 4.0% Pb, 3.52% Zn from 503.8m.

YTC’s CEO Rimas Kairaitis said these recent results are likely to increase the grade and the extent of the Hera Gold Deposit.

"The high‐grade northerly plunge appears open for +150m and has potential to make a significant addition to the updated Hera Resource. The Hera deposit continues to grow and YTC remains hopeful the deposit will continue to develop in to a scale to challenge other major Cobar Basin deposits,” he said.

A further hole returned 8m @ 5.5g/t Au, 18g/t Ag, 0.47% Cu, 2.3% Pb, 1.4% Zn from 430.5m and 3m @ 5.87/t Au, 26g/t Ag, 0.25% Cu, 9.8% Pb , 5.5% Zn from 448m.

Assays are pending from 451m to 498.5m.

A further 6 Resource drill holes still await assay results.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.